Gaoxiong Tower, #88, Gaoxiong Road, Jiangan District,Wuhan,Hubei,China:+86 185 0278 7239

Product Description

Estradiol cypionate

  • 313-06-4
  • C26H36O3

Brief Description

 

 

Product name

Estradiol Cypionate

Synonyms

Estradiol 17-Cypionate; estradiol 17-beta-cipionate; estradiol 17-beta-(3-cyclopentylpropionate); Oestradiol Cypionate; Estradiol Cypionate; 3-hydroxyestra-1,3,5(10)-trien-17-yl 3-cyclopentylpropanoate; (17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl 3-cyclopentylpropanoate; (8xi,9xi,14xi,17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl 3-cyclopentylpropanoate; Depofemin

MOQ

25KG

CAS No.

313-06-4

Appearance

  An almost white powder

Molecular Formula

C26H36O3

Molecular Weight

396.5622

Assay

99%

Application

Pharma grade or research purpose

Packing

As per your request

Storage

Preserve in tight, light-resistant containers in a cool place

Remarks

NA

Custom synthesis

Available

Supply Ability

10000kg/month

 

Medical use

 

The medical uses of estradiol cypionate are the same as those of estradiol and other estrogens. Examples of indications for the drug include hormone therapy and hormonal contraception. In regard to the latter, estradiol cypionate has been used in combination with medroxyprogesterone acetate as a combined injectable contraceptive. Along with estradiol valerate, estradiol undecylate, and estradiol benzoate, estradiol cypionate is used as a form of high-dose estrogen therapy in feminizing hormone therapy for transgender women.

 

Estradiol cypionate is usually used at a dosage of 1 to 5 mg by intramuscular injection every 3 to 4 weeks in the treatment of menopausal symptoms such as hot flashes and vaginal atrophy, at a dosage of 1.5 to 2 mg by intramuscular injection once a month in the treatment of female hypoestrogenism due to hypogonadism, and at a dosage of 2 to 10 mg by intramuscular injection once every 1 or 2 weeks for hormone therapy in transgender women.

 

 

Our Factory: